Bagan Leticia, Ocete-Monchon María-Dolores, Leopoldo-Rodado Manuel, Murillo-Cortes Judith, Díaz-Fernández Jose-M, Medina-Gonzalez Rafael, Gimeno-Cardona Concepción, Bagan Jose-V
Oral Medicine Department, C/ Gasco Oliag 1, 46010 Valencia, Spain,
Med Oral Patol Oral Cir Bucal. 2016 Mar 1;21(2):e157-60. doi: 10.4317/medoral.20785.
To analyze the presence of salivary Epstein-Barr virus (EBV) DNA in oral squamous cell carcinoma and potentially malignant oral disorders.
Three groups were studied: Group 1 (12 oral squamous cell carcinomas (OSCC)), Group 2 (12 potentially malignant oral disorders (PMD)) and Group 3 (47 healthy controls). EBV DNA salivary analysis was performed by PCR.
The highest percentage of positive salivary EBV DNA corresponded to the OSCC group (58.3%), followed by the PMD group (41.7%) and the controls (40.4%). The differences between groups were not statistically significant, however (p>0.05).
Salivary EBV DNA was more prevalent in OSCC than in PMD or the controls.
分析口腔鳞状细胞癌和潜在恶性口腔疾病中唾液 Epstein-Barr 病毒(EBV)DNA 的存在情况。
研究分为三组:第 1 组(12 例口腔鳞状细胞癌(OSCC))、第 2 组(12 例潜在恶性口腔疾病(PMD))和第 3 组(47 例健康对照)。通过聚合酶链反应(PCR)对唾液中的 EBV DNA 进行分析。
唾液 EBV DNA 阳性率最高的是 OSCC 组(58.3%),其次是 PMD 组(41.7%)和对照组(40.4%)。然而,各组之间的差异无统计学意义(p>0.05)。
唾液 EBV DNA 在 OSCC 中比在 PMD 或对照组中更普遍。